543828 — Sudarshan Pharma Industries Balance Sheet
0.000.00%
- IN₹6.47bn
- IN₹8.16bn
- IN₹5.05bn
- 64
- 32
- 36
- 39
Annual balance sheet for Sudarshan Pharma Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12.5 | 2.36 | 117 | 16.4 | 20.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 604 | 735 | 815 | 1,225 | 1,648 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 876 | 1,296 | 1,986 | 2,416 | 3,348 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 59.8 | 68.8 | 190 | 224 | 261 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 993 | 1,375 | 2,325 | 2,831 | 4,024 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 712 | 1,010 | 1,185 | 1,608 | 2,597 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 768 | 1,077 | 1,315 | 1,714 | 2,709 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 225 | 298 | 1,010 | 1,117 | 1,315 |
| Total Liabilities & Shareholders' Equity | 993 | 1,375 | 2,325 | 2,831 | 4,024 |
| Total Common Shares Outstanding |